GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (WBO:1SXP) » Definitions » 1-Year ROIIC %

Schott Pharma AG KGaA (WBO:1SXP) 1-Year ROIIC % : -4.19% (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Schott Pharma AG KGaA 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Schott Pharma AG KGaA's 1-Year ROIIC % for the quarter that ended in Dec. 2024 was -4.19%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Schott Pharma AG KGaA's 1-Year ROIIC % or its related term are showing as below:

WBO:1SXP's 1-Year ROIIC % is ranked worse than
56.74% of 823 companies
in the Medical Devices & Instruments industry
Industry Median: 1.81 vs WBO:1SXP: -4.19

Schott Pharma AG KGaA 1-Year ROIIC % Historical Data

The historical data trend for Schott Pharma AG KGaA's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA 1-Year ROIIC % Chart

Schott Pharma AG KGaA Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24
1-Year ROIIC %
- 16.80 10.05 413.82 14.30

Schott Pharma AG KGaA Quarterly Data
Sep20 Sep21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -8.96 14.30 -4.19

Competitive Comparison of Schott Pharma AG KGaA's 1-Year ROIIC %

For the Medical Instruments & Supplies subindustry, Schott Pharma AG KGaA's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Schott Pharma AG KGaA's 1-Year ROIIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Schott Pharma AG KGaA's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Schott Pharma AG KGaA's 1-Year ROIIC % falls into.



Schott Pharma AG KGaA 1-Year ROIIC % Calculation

Schott Pharma AG KGaA's 1-Year ROIIC % for the quarter that ended in Dec. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( 140.8217 (Dec. 2024) - 145.5075 (Dec. 2023) )/( 1111.332 (Dec. 2024) - 999.442 (Dec. 2023) )
=-4.6858/111.89
=-4.19%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Schott Pharma AG KGaA  (WBO:1SXP) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Schott Pharma AG KGaA 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Schott Pharma AG KGaA Business Description

Traded in Other Exchanges
Address
Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.

Schott Pharma AG KGaA Headlines

No Headlines